Science Explorer Interactive view Map
Research facility · San Francisco · United States

Parker Institute for Cancer Immunotherapy

In research, Parker Institute for Cancer Immunotherapy stands highest in Life Sciences (#293 of 7,800 worldwide), Medicine (#2,386 of 10,443 worldwide) and Health Sciences (#3,386 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Immunology, Oncology and Immunology and Microbiology — Immunology is 35.0× its share of world research.

World rank, 2022–2025
#945
of 28,054 · #1,774 all time
Rank in United States
#167
of 4,192
Research works
385
▲ 496% vs 2013–17
Citations
40k
104.1 per fractional work
Top-10% rate
50.1%
record average 16.5%
Open access
78%
world 28%

What is Parker Institute for Cancer Immunotherapy known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Life SciencesDomain #293 of 7,800 54.1%83 #663
MedicineField #2,386 of 10,443 44.0%82 #3588
Health SciencesDomain #3,386 of 11,982 43.9%82 #4976

Each strip is that field’s whole ranked pool, with the notch where Parker Institute for Cancer Immunotherapy sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Life Sciences#663 #293
  2. Medicine#3,588 #2,386
  3. Health Sciences#4,976 #3,386
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does Parker Institute for Cancer Immunotherapy specialise in?

Where its research is concentrated relative to its size: Immunology takes 35.0× the share of its output that it takes of world research.

  1. ImmunologySubfield · 41.9 works35×
  2. OncologySubfield · 47.8 works24×
  3. Immunology and MicrobiologyField · 42.2 works24×
  4. Molecular BiologySubfield · 25.2 works4.8×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.07× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.08× its world share, 38 worksBiochemistry, Geneti…Immunology and Microbiology: 24.10× its world share, 42 worksImmunology and Micro…Neuroscience: 0.65× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.69× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.26× its world share, 1 worksChemistryComputer Science: 0.01× its world share, 0 worksComputer ScienceEngineering: 0.26× its world share, 7 worksEngineeringEnvironmental Science: 0.03× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.05× its world share, 0 worksMaterials ScienceHealth Professions: 0.06× its world share, 0 worksHealth ProfessionsMedicine: 2.44× its world share, 82 worksMedicineNursing: 0.30× its world share, 0 worksNursingVeterinary: 0.71× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.01× its world share, 0 worksBusiness, Management…Decision Sciences: 0.03× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.04× its world share, 0 worksEconomics, Econometr…Psychology: 0.04× its world share, 0 worksPsychologyworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 24.1×. Every wedge is a field page.

Which keywords describe research at Parker Institute for Cancer Immunotherapy?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Tumor Microenvironment and Immunity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Immunotherapy39▲ 146×3 topics
  2. Immunotherapy37▲ 30×14 topics
  3. Tumor Regression30▲ 156×2 topics
  4. Lymphoma30▲ 105×3 topics
  5. CAR T Cells28▲ 223×1 topic
  6. Chimeric Antigen Receptor28▲ 223×1 topic
  7. Tumor Microenvironment19▲ 24×8 topics
  8. Immunity16▲ 23×7 topics
  9. Immune Checkpoint Blockade14▲ 73×1 topic
  10. PD-1 and PD-L114▲ 73×1 topic
  11. NK Cell Recognition14▲ 119×1 topic
  12. Natural Killer Cells14▲ 119×1 topic
  13. Innate Immunity13▲ 24×8 topics
  14. Antigen Presentation12▲ 76×2 topics
  15. Dendritic Cells10▲ 66×2 topics
  16. Tumor Antigen10▲ 93×1 topic
  17. Vaccine Adjuvants10▲ 93×1 topic
  18. Cancer10▲ 4.2×24 topics
  19. Inflammation8▲ 2.4×30 topics
  20. Gene Expression8▲ 7.9×9 topics
  21. TGF-ß8▲ 30×3 topics
  22. Autoimmunity8▲ 31×4 topics
  23. CD4+CD25+7▲ 123×1 topic
  24. Foxp37▲ 123×1 topic
  25. Gene Therapy7▲ 20×3 topics
  26. Glycosylation6▲ 31×3 topics
  27. RNA-Seq5▲ 27×2 topics
  28. Single-Cell5▲ 65×1 topic
  29. Transcriptomics5▲ 65×1 topic
  30. AAV4▲ 59×1 topic
  31. Metabolism4▲ 4.5×3 topics
  32. Viral Vectors4▲ 59×1 topic
  33. Activation4▲ 38×1 topic
  34. Macrophage4▲ 31×1 topic
  35. Monoclonal Antibodies4▲ 23×2 topics
  36. Targeted Therapy4▲ 9.4×5 topics
  37. Genome Engineering3▲ 30×1 topic
  38. Mammalian Cells3▲ 79×1 topic
  39. RNA-Guided3▲ 30×1 topic
  40. Recombinant Protein3▲ 79×1 topic

Which research topics does Parker Institute for Cancer Immunotherapy publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction and Immunotherapy and Immune Responses.

  1. 1 CAR-T cell therapy researchOncology 28 works
  2. 2 Cancer Immunotherapy and BiomarkersOncology 14 works
  3. 3 Immune Cell Function and InteractionImmunology 14 works
  4. 4 Immunotherapy and Immune ResponsesImmunology 10 works
  5. 5 T-cell and B-cell ImmunologyImmunology 7 works
  6. 6 Single-cell and spatial transcriptomicsMolecular Biology 5 works
  7. 7 Virus-based gene therapy researchGenetics 4 works
  8. 8 Immune cells in cancerImmunology 4 works
  9. 9 Viral Infectious Diseases and Gene Expression in InsectsMolecular Biology 3 works
  10. 10 CRISPR and Genetic EngineeringMolecular Biology 3 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available78.2%not open21.8%

World: 28% of research is openly available.

with international co-authors27.8%domestic only72.2%

World: 19% is written across borders.

How has Parker Institute for Cancer Immunotherapy's research output changed?

Output in 2018–2022 was 496% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Francisco

All research institutions in San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.